Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The BAFF / APRIL system as therapeutic target in multiple sclerosis.
Magliozzi R, Marastoni D, Calabrese M. Magliozzi R, et al. Among authors: marastoni d. Expert Opin Ther Targets. 2020 Nov;24(11):1135-1145. doi: 10.1080/14728222.2020.1821647. Epub 2020 Sep 24. Expert Opin Ther Targets. 2020. PMID: 32900236 Review.
Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis.
Magliozzi R, Hametner S, Facchiano F, Marastoni D, Rossi S, Castellaro M, Poli A, Lattanzi F, Visconti A, Nicholas R, Reynolds R, Monaco S, Lassmann H, Calabrese M. Magliozzi R, et al. Among authors: marastoni d. Ann Clin Transl Neurol. 2019 Nov;6(11):2150-2163. doi: 10.1002/acn3.50893. Epub 2019 Nov 1. Ann Clin Transl Neurol. 2019. PMID: 31675181 Free PMC article.
The CSF Profile Linked to Cortical Damage Predicts Multiple Sclerosis Activity.
Magliozzi R, Scalfari A, Pisani AI, Ziccardi S, Marastoni D, Pizzini FB, Bajrami A, Tamanti A, Guandalini M, Bonomi S, Rossi S, Mazziotti V, Castellaro M, Montemezzi S, Rasia S, Capra R, Pitteri M, Romualdi C, Reynolds R, Calabrese M. Magliozzi R, et al. Among authors: marastoni d. Ann Neurol. 2020 Sep;88(3):562-573. doi: 10.1002/ana.25786. Epub 2020 Jul 9. Ann Neurol. 2020. PMID: 32418239
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis.
Sormani MP, De Rossi N, Schiavetti I, Carmisciano L, Cordioli C, Moiola L, Radaelli M, Immovilli P, Capobianco M, Trojano M, Zaratin P, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M; Musc-19 Study Group. Sormani MP, et al. Ann Neurol. 2021 Apr;89(4):780-789. doi: 10.1002/ana.26028. Epub 2021 Feb 9. Ann Neurol. 2021. PMID: 33480077 Free PMC article.
43 results